Does Fibrates Interact with Bempedoic Acid And Ezetimibe?
Fibrates and Bempedoic Acid And Ezetimibe have a moderate drug interaction according to U.S. FDA drug labeling data. Concomitant use with bempedoic acid resulted in increased triglycerides and decreased HDL-C in some patients. Monitor lipid levels four weeks after initiation and periodically thereafter. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Bempedoic Acid And Ezetimibe Class
- Adenosine Triphosphate-Citrate Lyase Inhibitor
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
What To Tell Your Doctor or Pharmacist
If you are taking Fibrates and your doctor is considering prescribing Bempedoic Acid And Ezetimibe (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider